Global Pancreatitis Market – Industry Trends and Forecast to 2029

Market Analysis and Size                              

Every year, over 275,000 people in the United States are hospitalized to the hospital with acute pancreatitis, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Pancreatitis occurs when the pancreas becomes inflamed and irritated (swollen). It isn't a common ailment. Gallstones or excessive alcohol consumption are the most frequent causes. The disease can appear unexpectedly or develop over time, resulting in severe harm. Pancreatitis treatment may involve intravenous (IV) fluids, pain medication, and other medications.

Data Bridge Market Research analyses that the pancreatitis market was valued at USD 8.71 billion in 2021 and is expected to reach USD 13.58 billion by 2029, registering a CAGR of 5.70% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Pancreatitis is characterized by the inflammation of the pancreas. The pancreas is located in the upper belly, nestled below the stomach. The pancreas generates digestive enzymes as well as hormones that assist regulate sugar metabolism (glucose). Fluids and nourishment are either intravenously (IV) or through a nasogastric feeding tube that passes straight from your nose to your stomach in the treatment of acute or chronic pancreatitis. Medication such as analgesics assist with pain management. Complications usually demand surgery including gallbladder surgery, endoscopic retrograde cholangiopancreatography (ERCP)

Pancreatitis Market Dynamics

Drivers

• High prevalence rate of acute pancreatitis

The rise in prevalence rate of acute pancreatitis across the globe will act as a major driver that will result in the expansion of the growth rate of the market. Acute pancreatitis is caused by gallstones and high alcohol consumption, especially in the younger population. According to an article published in the World Journal of Clinical Cases- Evaluation and management of acute pancreatitis in 2019, gallstones are the most common cause of acute pancreatitis (AP), accounting for 28 percent to 38 percent of all cases, while alcohol consumption is the second most common cause, accounting for 19 percent to 41 percent of all acute pancreatitis cases. The increased number of patients with gallstones raises the risk of acute pancreatitis.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of pancreatitis market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

• Rising incidences of diabetes

The increasing incidences of diabetes is expected to enhance the market’s growth rate. Pancreatitis can harm insulin-producing cells. Insulin is a hormone produced by the pancreas that helps to regulate blood sugar levels. When pancreatitis destroys these cells, roughly 45 percent of persons with chronic pancreatitis develop diabetes.

Furthermore, surging number of government initiatives to spread awareness and increasing number of geriatric population will result in the expansion of pancreatitis market. Along with this, changing lifestyle of people and growing government favourable initiatives will enhance the growth rate of the market. Also, rising prevalence of pancreatic cancer as well as obesity will propel the growth rate of market.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the pancreatitis market growth.

Moreover, the market's growth is fueled by investment for the development of advanced technologies and increase in the number of emerging markets. These factors will provide beneficial opportunities for the pancreatitis market growth.

Restraints/Challenges

On the other hand, the high cost associated with the treatment will obstruct the growth rate of pancreatitis market during the forecast period of 2022-2029. The lack of healthcare infrastructure in developing economies and strict regulatory scenario will challenge the pancreatitis market. Additionally, lack of awareness among people and poor reimbursement policies will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This pancreatitis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pancreatitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Pancreatitis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Recent Development

• In January 2021, Trevena, Inc. had announced the launch of opiod based medicine named Olinvyk (oliceridine) for the treatment of acute pain in adults. Olinvyk (oliceridine) was approved by FDA in August, 2020. OLINVYK contains oliceridine, an opioid-like Schedule II restricted narcotic with a significant potential for abuse.

Global Pancreatitis Market Scope

The pancreatitis market is segmented on the basis of type, causes, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Acute Pancreatitis
• Chronic Pancreatitis

Causes

• Gall Stones
• Alcohol
• Drugs
• Others

Treatment

• Analgesics
• Intravenous (IV) Fluids
• Gallbladder Surgery
• Endoscopic Retrograde Cholangiopancreatography (ERCP)
• Others

Diagnosis

• Blood Tests
• Abdominal Ultrasound
• Computerized Tomography (CT) Scan
• Magnetic Resonance Imaging (MRI)
• Endoscopic Ultrasound
• Stool Tests
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Pancreatitis Market Regional Analysis/Insights

The pancreatitis market is analysed and market size insights and trends are provided by country, type, causes, treatment, diagnosis, route of administration, end-users and distribution channel as referenced above.

The countries covered in the pancreatitis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the pancreatitis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing demand for specific treatment and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, presence of major key players and rise in adoption of newer technologies will further propel the market’s growth rate in this region.

Asia-Pacific is expected to be the fastest growing region during the forecast period of 2022-2029 due to growing cases of pancreatitis in this region. Also, development of healthcare infrastructure and rising government initiatives will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Pancreatitis Market Share Analysis

The pancreatitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pancreatitis market.

Some of the major players operating in the pancreatitis market are:

• Pfizer Inc. (U.S.)
• GlaxoSmithKline plc (U.K.)
• Novartis AG (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Merck & Co., Inc. (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Baxter (U.S.)
• Bayer AG (Germany)
• Eli Lilly and Company (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Lupin (India)
• Allergan (Ireland)
• AbbVie Inc. (U.S.)
• Abbott (U.S.)
• Bausch Health Companies Inc. (Canada)

SKU-53376